Among adults with outpatient respiratory syncytial virus (RSV) infections across six RSV seasons, roughly one in 20 were ...

Merck said on Tuesday a study showed its injectable version of cancer drug Keytruda was not inferior to the currently ...

Experts view BridgeBio’s acoramidis—which has an FDA action date of Nov. 29—as either similar to or incrementally better than ...

Among participants in the landmark ORAL Surveillance study assigned to the JAK inhibitor tofacitinib (Xeljanz) and also using ...

Patients with GPA completely weaned off glucocorticoids were four times as likely to flare compared with those kept on a low ...

Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration ...

The stock market's "Trump bump" that followed his victory over Vice President Kamala Harris in last week's election appears ...

U.S. stocks suffered their worst loss since election day as the boost from Donald Trump's victory and a Federal Reserve ...

U.S. stocks fell to their worst loss since Election Day as the boost that Wall Street got from last week’s victory for Donald ...

Donald Trump has delivered a blow to the drug makers he claims hampered his 2020 election bid with the appointment of vaccine ...

A mother says years of painful headaches and speech issues from brain tumors were caused by prolonged use of a Pfizer birth ...

The news outlet is pushing the Commission to release text messages that the E.U.’s top official and Pfizer exchanged as they ...